GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vasamed Inc (OTCPK:VSMD) » Definitions » Cash, Cash Equivalents, Marketable Securities

Vasamed (Vasamed) Cash, Cash Equivalents, Marketable Securities : $0.63 Mil (As of Sep. 2006)


View and export this data going back to 1996. Start your Free Trial

What is Vasamed Cash, Cash Equivalents, Marketable Securities?

Vasamed's quarterly cash, cash equivalents, marketable securities declined from Mar. 2006 ($1.54 Mil) to Jun. 2006 ($0.95 Mil) but then stayed the same from Jun. 2006 ($0.95 Mil) to Sep. 2006 ($0.63 Mil).

Vasamed's annual cash, cash equivalents, marketable securities declined from Dec. 2003 ($0.02 Mil) to Dec. 2004 ($0.01 Mil) and declined from Dec. 2004 ($0.01 Mil) to Dec. 2005 ($0.00 Mil).


Vasamed Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Vasamed's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vasamed Cash, Cash Equivalents, Marketable Securities Chart

Vasamed Annual Data
Trend Dec96 Dec97 Dec98 Dec99 Dec00 Dec01 Dec02 Dec03 Dec04 Dec05
Cash, Cash Equivalents, Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.67 0.24 0.02 0.01 -

Vasamed Quarterly Data
Dec01 Mar02 Jun02 Sep02 Dec02 Mar03 Jun03 Sep03 Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.77 - 1.54 0.95 0.63

Vasamed Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Vasamed  (OTCPK:VSMD) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Vasamed Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Vasamed's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Vasamed (Vasamed) Business Description

Industry
Traded in Other Exchanges
N/A
Address
7615 Golden Triangle Drive, Suite A, Eden Prairie, MN, USA, 55344-3733
Vasamed Inc develops, manufactures and markets low-cost, non-invasive peripheral and cardiovascular diagnostic systems for hemodynamic assessment.

Vasamed (Vasamed) Headlines

No Headlines